Erika Ashley Fisher, Chief Legal Officer of HubSpot Inc., filed a Form 4 on November 3, 2026, disclosing a tax-related share withholding transaction in HubSpot common stock dated November 2, 2026.
Enrique Minarro Viseras, Executive Vice President and Chief Operating Officer of Otis Worldwide Corp, filed a Form 4 on November 3, 2026, disclosing the vesting of the third and final installment of a restricted stock unit grant originally made on November 1, 2023.
Charles Baker, an officer of Etsy Inc, filed a Form 144 notice of proposed sale of 1,407 shares of Etsy common stock on November 3, 2026, following an RSU vesting on November 1, 2026.
Radian Group Inc. filed an 8-K on November 3, 2026, disclosing that its wholly-owned subsidiary Inigo Corporate Member Limited entered into a Fifth Amendment and Restatement Agreement on October 29, 2026, increasing its letter of credit facility from $620 million to $880 million and …
Huntington Bancshares Inc /MD/ officer Donnell R. White filed a Form 144 notice on November 3, 2026, disclosing a proposed sale of 3,000 shares of Huntington Bancshares common stock through Fidelity Brokerage Services LLC.
Alan R. Pickerill, a director of Porch Group, Inc., filed a Form 144 notice of proposed sale of 10,000 shares of common stock, with an approximate sale date of November 3, 2026, through Morgan Stanley Smith Barney LLC Executive Financial Services.
Richard G. Thornberry, a former officer of Radian Group Inc, filed a Form 144 notice of proposed sale of securities on November 3, 2026, covering 26,237 shares of Radian common stock with an aggregate market value of $946,147.69.
Kestra Medical Technologies, Ltd. officer Timothy P. Moran filed a Form 144 notice of proposed sale on November 3, 2026, covering 3,192 shares of common stock acquired through the vesting of performance share unit awards.
Director Michael S. Brown filed a Form 4 with the SEC on November 3, 2026, disclosing the exercise of 1,929 non-qualified stock options and the same-day sale of 1,929 shares of Regeneron Pharmaceuticals, Inc. common stock on October 30, 2026.
CNA Financial Corporation officer Scott Lindquist filed a Form 144 notice on November 3, 2026, disclosing a proposed sale of 23,579 shares of CNA Financial common stock through Morgan Stanley Smith Barney LLC.